Croda International Plc (LON:CRDA – Get Free Report) insider Steve Foots purchased 5 shares of the business’s stock in a transaction dated Monday, August 10th. The shares were purchased at an average cost of GBX 3,292 per share, for a total transaction of £164.60.
Steve Foots also recently made the following trade(s):
- On Friday, July 10th, Steve Foots bought 5 shares of Croda International stock. The shares were acquired at an average price of GBX 2,859 per share, for a total transaction of £142.95.
- On Wednesday, June 10th, Steve Foots purchased 5 shares of Croda International stock. The stock was acquired at an average price of GBX 2,965 per share, with a total value of £148.25.
Croda International Price Performance
Shares of LON:CRDA opened at GBX 3,274 on Tuesday. The firm has a market cap of £4.56 billion, a PE ratio of 57.54, a price-to-earnings-growth ratio of 1.40 and a beta of 0.92. The firm’s fifty day moving average is GBX 3,041.96 and its 200-day moving average is GBX 2,935.61. The company has a debt-to-equity ratio of 36.06, a quick ratio of 2.25 and a current ratio of 2.57. Croda International Plc has a 52 week low of GBX 2,426.77 and a 52 week high of GBX 3,352.
Wall Street Analyst Weigh In
CRDA has been the subject of several analyst reports. Berenberg Bank restated a “buy” rating and set a GBX 3,600 price target on shares of Croda International in a report on Wednesday, July 29th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a GBX 3,300 price target on shares of Croda International in a report on Wednesday, July 29th. Citigroup upped their price target on Croda International from GBX 3,050 to GBX 3,200 and gave the stock a “neutral” rating in a research note on Wednesday, July 29th. Finally, Jefferies Financial Group reissued a “buy” rating and issued a GBX 3,500 price target on shares of Croda International in a research report on Wednesday, July 29th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of GBX 3,390.
Check Out Our Latest Stock Analysis on CRDA
Croda International Company Profile
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Read More
- Five stocks we like better than Croda International
- China’s Athleisure Boom Is Not Lifting Every Brand Equally
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.
